Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

The Senza spinal cord stimulation system has been approved by the U.S. Food and Drug Administration to treat chronic intractable pain of the trunk and/or limbs

FDA: Senza Device Relieves Spinal Pain Without Paresthesia

Implanted device treats chronic back pain
Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market

FDA Petitioned to Stop Sales of Essure Implant

Reported complications include back and pelvic pain, dislodged coils, heavy prolonged menstrual periods
Raplixa (human fibrin sealant) has been approved by the U.S. Food and Drug Administration to help control bleeding during surgery

FDA Approves Raplixa to Help Control Surgical Bleeding

Spray-dried fibrin sealant promotes clotting when other methods are 'ineffective or impractical'
The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

FDA Approves First Generic Abilify

For treatment of bipolar disorder or schizophrenia
Kybella (deoxycholic acid) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe submental fat.

FDA Approves Kybella for Reducing Submental Fat

Use for fat outside submental area not approved, not recommended
Counterfeit Botox may have been distributed to doctors' offices and medical clinics across the United States

FDA: Counterfeit Botox Found in the United States

Agency recommends physicians closely examine Botox packaging
Corlanor (ivabradine) has been approved by the U.S. Food and Drug Administration to treat chronic heart failure

FDA Approves Corlanor for Chronic Heart Failure

Works by decreasing heart rate; first approved product in this drug class
The first U.S. generic version of Copaxone (glatiramer acetate injection) has been approved by the Food and Drug Administration to treat multiple sclerosis.

FDA: Generic Copaxone Approved for Multiple Sclerosis

FDA reviewed additional information to ensure generic is as safe and effective as brand-name drug
A new breath test (the Gastric Emptying Breath Test) has been approved by the U.S. Food and Drug Administration to aid in the diagnosis of gastroparesis.

FDA Approves New Test That Helps Diagnose Gastroparesis

Test is less invasive and can be administered in the physician's office
The Impella 2.5 System has been approved by the U.S. Food and Drug Administration to maintain stable heart function and blood circulation during high-risk cardiac operations

FDA Approves New Miniature Blood Pump System

Maintains circulation during high-risk percutaneous coronary intervention procedures